DNA interaction and cytostatic activity of the new liver organotropic complex of cisplatin with glycocholic acid: Bamet-R2

Int J Cancer. 1998 Oct 29;78(3):346-52. doi: 10.1002/(SICI)1097-0215(19981029)78:3<346::AID-IJC15>3.0.CO;2-4.

Abstract

The aim of this study was to investigate the ability of the new liver organotropic complex of cisplatin with glycocholate (GC), Bamet-R2, to interact with DNA, inhibit its replication and hence reduce tumor-cell proliferation. Changes in the electrophoretic mobility of the open and covalently closed circular forms of the pUC18 plasmid DNA from Escherichia coli, a shift in the denaturation temperature of double-stranded DNA, and ethidium-bromide displacement from DNA binding, were induced by Bamet-R2 and cisplatin, but not by GC. Neutral-red retention was used to measure the number of living cells in culture after long-term (72-hr) exposure to these compounds and to evaluate the effect on cell viability after short-term (6-hr) exposure. Bamet-R2 and cisplatin, but not GC, induced significant inhibition of cell growth. This effect ranged from mild to strong, depending upon the sensitivity of the different cell types as follows: cisplatin, rat hepatocytes in primary culture < rat hepatoma McA-RH7777 cells (rH) < human colon carcinoma LS 174T cells (hCC) < mouse hepatoma Hepa 1-6 cells (mH); Bamet-R2, rat hepatocytes < mH approximately equal to hCC < rH. DNA synthesis was measured by radiolabeled-thymidine incorporation into DNA. Bamet-R2 and cisplatin, but not GC, significantly inhibited the rate of DNA synthesis by these cells. After short-term exposure to Bamet-R2 or GC, no acute cell toxicity was observed, except on hCC cells. By contrast, acute toxicity was induced by cisplatin for all cell types studied. The in vivo anti-tumoral effect was investigated in 3 different strains of mice following s.c. implantation of tumor cells (mouse sarcoma S-18011 cells in Swiss and B6 mice and hCC cells in nude mice). In all 3 models, tumor growth was inhibited by Bamet-R2 and cisplatin to a similar degree. However, signs of toxicity (increases in blood urea concentrations and decreases in packed blood cell volume and in liver, kidney and body weight) and a reduction in survival rate were observed only during cisplatin administration. In sum, these results indicate that this bile-acid derivative can be considered as a cytostatic drug whose potential usefulness deserves further investigation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / toxicity*
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cisplatin / analogs & derivatives*
  • Cisplatin / chemistry
  • Cisplatin / toxicity
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / pathology
  • DNA / chemistry*
  • DNA / drug effects
  • DNA Replication / drug effects
  • Ethidium / chemistry
  • Ethidium / pharmacology
  • Glycocholic Acid / analogs & derivatives*
  • Glycocholic Acid / chemistry
  • Glycocholic Acid / toxicity
  • Humans
  • Liver / cytology
  • Liver / drug effects*
  • Liver / pathology
  • Liver Neoplasms, Experimental
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred Strains
  • Mice, Nude
  • Organoplatinum Compounds / chemistry*
  • Organoplatinum Compounds / toxicity*
  • Rats
  • Rats, Wistar
  • Transplantation, Heterologous
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • diaminneplatinum(II)-chlorocholylglycinate
  • DNA
  • Ethidium
  • Glycocholic Acid
  • Cisplatin